DOI: 10.4244/EIJV9I9A189

What embolises to the brain during transcatheter aortic valve implantation?

Nicolas M. Van Mieghem1*, MD; Marguerite E.I. Schipper2, MD; Peter P. de Jaegere1, MD, PhD

An 83-year-old female patient underwent a transcatheter aortic valve implantation (TAVI) for symptomatic severe aortic stenosis with a high operative risk (logistic EuroSCORE 45%). The procedure was performed using the Montage™ Dual Filter embolic protection device (EPD) (Claret Medical, Inc., Santa Rosa, CA, USA), inserted through a right radial artery and encompassing the deployment of a proximal filter basket in the brachiocephalic trunk and a distal filter basket in the left common carotid artery (Figure 1A and Figure 1B). The procedure evolved uneventfully with successful deployment of a 29 mm Medtronic CoreValve™ (Medtronic Inc., Minneapolis, MN, USA) (Figure 1C). The EPD was then retrieved and contained a mixture of red and white material (with sizes varying from 1.5 to 7.1 mm) (Figure 1D). Figure 1E illustrates microscopic (magnification 2x) overview of two different fragments after haematoxylin & eosin (H&E) staining with material resembling tissue (*) and thrombus (**). Further analysis (magnification 20x) of the tissue fragment (Figure 1F) shows spindle-shaped fibroblasts with small purple nuclei and vacuolated proteoglycan-rich cytoplasm (light blue) partly covered by remnants of endothelial lining. These features can stem from large elastic arteries but seem more compatible with aortic valve leaflet origin given the absence of atherosclerosis or other typical hallmarks of vessel structures and bearing in mind the aortic root instrumentation during TAVI. Figure 1G (magnification 20x) demonstrates fibrin material (dark pink) mixed with clusters of platelets (blue), white blood cells (purple) and erythrocytes (red) and represents typical thrombus formation. Further research is warranted to assess whether the use of embolic protection devices will reduce the incidence of TAVI-related cerebrovascular embolisation and procedural stroke.

Figure 1. Transcatheter aortic valve implantation under cerebral embolic protection with the Montage Dual Filter and analysis of captured debris.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 9 Number 9
Jan 20, 2014
Volume 9 Number 9
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-23-00052 Mar 18, 2024
Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation
Joner M and Wild L
free

Debate

10.4244/EIJ-E-24-00005 Mar 18, 2024
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
McEntegart M et al
free

Original Research

10.4244/EIJ-D-23-00783 Mar 18, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
Meier D et al
Trending articles
281.53

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved